Table 2

Acquired variants identified by whole-exome sequencing

GeneMouse variantReported mutation(s) in patients*Classification in mouse WES
Kras p.G12D p.G12D Unique 
Celsr1 p.R2319W p.P2600H Unique 
Kmt2a (MLL1) p.T1311I translocations, PTD Recurrent 
Ttn p.G11436R p.E12813K, p.I13568_ins Recurrent 
Brinp3 (FAM5C) 3′UTR* p.R719C, p.T119S Not in “high confidence” 
Npm1 V60I frameshift in last exon Not in “high confidence” 
Tead1 3′UTR p.I12S Not in “high confidence” 
GeneMouse variantReported mutation(s) in patients*Classification in mouse WES
Kras p.G12D p.G12D Unique 
Celsr1 p.R2319W p.P2600H Unique 
Kmt2a (MLL1) p.T1311I translocations, PTD Recurrent 
Ttn p.G11436R p.E12813K, p.I13568_ins Recurrent 
Brinp3 (FAM5C) 3′UTR* p.R719C, p.T119S Not in “high confidence” 
Npm1 V60I frameshift in last exon Not in “high confidence” 
Tead1 3′UTR p.I12S Not in “high confidence” 

_ins, in-frame insertion; PTD, partial tandem duplication; 3′UTR*, change predicted by SnpEff to lead to increased nonsense-mediated decay; WES, whole-exome sequencing.

*

Mutations reported in patients with hematological malignancies.

Variants identified in 1 mouse disease sample (“unique”) or in multiple disease samples (“recurrent”) compared with control DNA, with predicted amino acid change. Not in “high confidence” variants are only identified when compared with one control sample individually.

Close Modal

or Create an Account

Close Modal
Close Modal